BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30738642)

  • 1. Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.
    Kim S; Graham MJ; Lee RG; Yang L; Kim S; Subramanian V; Layne JD; Cai L; Temel RE; Shih D; Lusis AJ; Berliner JA; Lee S
    Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):306-315. PubMed ID: 30738642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.
    Kim S; Yang L; Kim S; Lee RG; Graham MJ; Berliner JA; Lusis AJ; Cai L; Temel RE; Rateri DL; Lee S
    PLoS One; 2017; 12(8):e0182566. PubMed ID: 28792970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr
    Yang ZH; Gordon SM; Sviridov D; Wang S; Danner RL; Pryor M; Vaisman B; Shichijo Y; Doisaki N; Remaley AT
    Atherosclerosis; 2017 Jul; 262():31-38. PubMed ID: 28486149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis.
    Hannemann C; Schecker JH; Brettschneider A; Grune J; Rösener N; Weller A; Stangl V; Fisher EA; Stangl K; Ludwig A; Hewing B
    Cardiovasc Res; 2022 Jan; 118(1):156-168. PubMed ID: 33576385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr
    Rajamoorthi A; Lee RG; Baldán Á
    Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.
    Fan Q; Yin X; Rababa'h A; Diaz Diaz A; Wijaya CS; Singh S; Suryavanshi SV; Vo HH; Saeed M; Zhang Y; McConnell BK
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H793-H810. PubMed ID: 31441691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.
    Distel E; Barrett TJ; Chung K; Girgis NM; Parathath S; Essau CC; Murphy AJ; Moore KJ; Fisher EA
    Circ Res; 2014 Oct; 115(9):759-69. PubMed ID: 25201910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
    Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
    Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression.
    Bartels ED; Christoffersen C; Lindholm MW; Nielsen LB
    Circ Res; 2015 Nov; 117(11):933-42. PubMed ID: 26358193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
    Wang Y; Tang W; Yang P; Shin H; Li Q
    Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
    Yan H; Niimi M; Matsuhisa F; Zhou H; Kitajima S; Chen Y; Wang C; Yang X; Yao J; Yang D; Zhang J; Murakami M; Nakajima K; Wang Y; Liu E; Liang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2095-2107. PubMed ID: 32757647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
    Andersson KE; Svedberg KA; Lindholm MW; Oste R; Hellstrand P
    Atherosclerosis; 2010 Sep; 212(1):93-9. PubMed ID: 20553794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.